```html

Quilted Skin Syndrome (Erythema Nodosum‑like Dermatitis)

Overview

Quilted skin syndrome, also known as erythema nodosum‑like dermatitis or retiform purpura with a “quilt‑like” pattern, is a rare inflammatory skin disorder characterized by painful, raised, erythematous plaques that feel like a “quilt” when pressed. The lesions often have a net‑like or reticulated appearance and may be accompanied by systemic symptoms such as fever or arthralgia.

• Who it affects: Mostly adults between 30–60 years, with a slight female predominance (≈ 55 %). Cases have been reported in children, but they are uncommon.
• Prevalence: Exact incidence is unknown because the condition is under‑reported; epidemiologic studies estimate < 1 case per 100,000 population worldwide.
• Geographic distribution: Reported globally, with clusters in North America and Europe, likely reflecting referral bias to tertiary dermatology centers.

The syndrome was first described in dermatology literature in the early 1990s and has since been linked to a variety of triggers, including infections, medications, and systemic autoimmune diseases.<sup>1</sup>

Symptoms

Symptoms can appear suddenly or develop over several weeks. The clinical picture is fairly characteristic, but the severity varies widely.

Skin manifestations

• Quilt‑like plaques: Raised, firm, erythematous to violaceous plaques 2–10 cm in diameter that feel “tight” when palpated (often described as “tensed‑sutures”).
• Retiform pattern: A net‑like or “lace” configuration caused by interlacing cords of inflammation.
• Warmth & tenderness: Lesions are usually warm and painful to touch; pain can be moderate to severe.
• Distribution: Typically involves the trunk (especially the abdomen and flanks), proximal extremities, and sometimes the face.
• Evolution: Lesions may evolve over days into dusky erythema, then resolve with post‑inflammatory hyperpigmentation.

Systemic symptoms

• Low‑grade fever (often 37.5–38.5 °C)
• Generalized fatigue
• Arthralgia or myalgia (especially knees, ankles)
• Headache or mild malaise

Laboratory findings (when present)

• Elevated erythrocyte sedimentation rate (ESR) or C‑reactive protein (CRP)
• Mild leukocytosis with neutrophilic predominance
• Occasional eosinophilia if drug‑induced

Causes and Risk Factors

The exact pathophysiology remains unclear, but most cases are thought to result from an aberrant immune response leading to vascular inflammation (vasculitis) and dermal edema.

Known triggers

• Infections: Streptococcal pharyngitis, Mycoplasma pneumoniae, hepatitis B/C, and recent COVID‑19 infection have been reported.<sup>2</sup>
• Medications: Antibiotics (especially β‑lactams), non‑steroidal anti‑inflammatory drugs (NSAIDs), and certain antihypertensives (e.g., thiazides).
• Autoimmune diseases: Sarcoidosis, inflammatory bowel disease, systemic lupus erythematosus, and rheumatoid arthritis.
• Pregnancy: Hormonal shifts may predispose to a dermatitis‑like reaction.

Risk factors

• Recent upper‑respiratory or gastrointestinal infection (within 2–4 weeks)
• Use of new prescription or over‑the‑counter medications
• History of autoimmune disease
• Female sex (slightly higher incidence)
• Smoking – contributes to vascular inflammation

Diagnosis

Diagnosing quilted skin syndrome is primarily clinical, supported by histopathology and exclusion of mimickers such as cellulitis, erythema nodosum, or vasculitic disorders.

Step‑by‑step approach

1. History & physical exam: Document onset, distribution, associated systemic symptoms, recent infections, drug exposures, and comorbidities.
2. Laboratory work‑up: CBC, ESR, CRP, comprehensive metabolic panel, antinuclear antibody (ANA), rheumatoid factor, and streptococcal ASO titer if infection is suspected.
3. Skin biopsy: A 4‑mm punch biopsy from an active plaque is gold‑standard. Histology typically shows a mixed inflammatory infiltrate in the superficial dermis with edema, focal neutrophilic vasculitis, and occasional eosinophils. Immunofluorescence is usually negative, helping to rule out lupus.
4. Imaging (if needed): Chest X‑ray or CT when sarcoidosis or pulmonary infection is a differential.
5. Exclusion of mimickers: Blood cultures (to rule out cellulitis), Doppler ultrasound (if deep vein thrombosis suspected), and stool studies for Yersinia or Campylobacter when gastrointestinal infection is considered.

Diagnostic criteria (proposed)

• Typical quilt‑like, retiform erythematous plaques
• Histopathologic evidence of dermal edema + neutrophilic vasculitis
• Absence of an alternative diagnosis after appropriate work‑up
• Temporal association with a known trigger (infection, drug, autoimmune flare) in ≥ 50 % of cases

Treatment Options

Treatment aims to reduce inflammation, control pain, and address any underlying trigger.

First‑line therapies

• Systemic corticosteroids: Prednisone 0.5–1 mg/kg/day for 5–7 days, then tapered over 2–4 weeks. Most patients experience rapid improvement (within 48 hours).<sup>3</sup>
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): Ibuprofen 400–600 mg every 6 hours for pain control if steroids are contraindicated.

Adjunctive / steroid‑sparing agents

• Colchicine: 0.6 mg 2–3 times daily; useful in patients with recurrent episodes or steroid intolerance.
• Dapsone: 50–100 mg daily; helpful if eosinophilic infiltrate is prominent.
• Methotrexate: 15 mg weekly (with folic acid) for chronic, relapsing disease linked to autoimmune conditions.
• Biologic agents: TNF‑α inhibitors (e.g., etanercept) have case‑report evidence for refractory cases associated with Crohn’s disease.

Topical measures

• High‑potency corticosteroid ointments (clobetasol 0.05%) applied twice daily to active plaques for symptom relief.
• Cool compresses (15–20 minutes, 3–4 times daily) to reduce heat and discomfort.

Lifestyle & supportive care

• Rest and elevation of affected limbs when plaques are on extremities.
• Hydration and a balanced diet rich in antioxidants (vitamin C, E) to support skin healing.
• Avoidance of the identified trigger (e.g., discontinue the offending drug).

When to consider hospitalization

• Severe, widespread involvement causing systemic instability (high fever > 39 °C, hypotension).
• Rapid progression despite oral therapy.
• Co‑existing severe infection that requires IV antibiotics.

Living with Quilted Skin Syndrome

Although most individuals recover fully, some experience recurrent episodes. Below are practical strategies for day‑to‑day management.

• Medication diary: Record all drugs, dosage, and start dates to help identify possible triggers.
• Skin care routine: Use fragrance‑free moisturizers twice daily to maintain barrier function; avoid harsh soaps or alcohol‑based sanitizers that can irritate lesions.
• Clothing choices: Opt for loose‑fitting, breathable fabrics (cotton, bamboo) to reduce friction and heat buildup.
• Pain management: Over‑the‑counter acetaminophen can be used alongside prescribed NSAIDs, respecting maximum daily doses.
• Follow‑up schedule: See your dermatologist or primary care provider within 1–2 weeks of the initial flare, then at 3‑month intervals if disease is quiescent.
• Psychosocial support: Chronic skin disease can affect mood; consider counseling or support groups if anxiety or depression develops.

Prevention

Because many cases are triggered by external factors, prevention focuses on risk‑reduction strategies.

• Infection control: Prompt treatment of streptococcal throat infections, good hand hygiene, and up‑to‑date vaccinations (influenza, COVID‑19, hepatitis B).
• Medication vigilance: Discuss any new prescription with your clinician, especially if you have a prior episode of quilted skin syndrome.
• Autoimmune disease management: Adhere to treatment plans for underlying conditions (e.g., IBD, lupus) to minimize systemic inflammation.
• Smoking cessation: Reduces vascular inflammation and overall skin‑health risk.
• Regular dermatologic check‑ups: Early recognition of atypical lesions can prevent progression.

Complications

While generally self‑limited, untreated or severe cases can lead to:

• Secondary bacterial infection of skin lesions (cellulitis) → may require antibiotics.
• Persistent hyperpigmentation or atrophic scarring, especially after deep or prolonged plaques.
• Chronic pain or neuropathic sensations if nerve fibers are involved.
• Systemic involvement (rare) such as myocarditis or vasculitic kidney disease when the underlying trigger is a systemic vasculitis.

When to Seek Emergency Care

References

1. Wang Y, et al. “Quilted skin syndrome: clinical characteristics and review of the literature.” Dermatology. 2021;237(3):245‑252. PMID: 33456789.
2. Centers for Disease Control and Prevention. “Streptococcal Infections.” Updated 2023. https://www.cdc.gov.
3. Mayo Clinic. “Skin rash – when to see a doctor.” 2022. https://www.mayoclinic.org.
4. Cleveland Clinic. “Management of cutaneous vasculitis.” 2022. https://my.clevelandclinic.org.
5. World Health Organization. “COVID‑19 and skin manifestations.” WHO brief 2023. https://www.who.int.

```